Headquartered in Chicago, Illinois, Ventas, Inc. (VTR) is a leading real estate investment trust (REIT) focused on properties serving the aging population. With a market capitalization of $43.8 billion, the company’s portfolio includes senior housing, healthcare facilities, and research-oriented properties, generating rental income while supporting environments that promote healthier, longer lives.
VTR is set to report its Q3 fiscal 2026 earnings on Tuesday, October 27, 2026, after the market closes. Ahead of the release, analysts expect the company to report diluted EPS of 98 cents, up 11.4% from 88 cents in the year-ago quarter. Moreover, VTR has met or exceeded Wall Street’s EPS estimates in each of the past four quarters, which is impressive.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
For fiscal 2026, analysts expect VTR to report EPS of $3.89, reflecting an 11.8% increase from $3.48 in fiscal 2025. EPS is projected to increase another 10% year over year to $4.28 in fiscal 2027.
www.barchart.comVTR stock has climbed 23.5% over the past 52 weeks, outperforming the S&P 500 Index ($SPX), which gained 14.4%, and the State Street Real Estate Select Sector SPDR ETF (XLRE), which declined marginally over the same period.
www.barchart.comOn Oct. 15, Ventas paid a quarterly cash dividend of 52 cents per common share. The distribution reflects Ventas’ continued commitment to returning capital to shareholders while investing in healthcare real estate, including senior housing and medical facilities.
Analysts remain bullish on VTR, with the stock carrying a consensus “Strong Buy” rating. Of the 23 analysts covering the stock, 16 recommend a “Strong Buy,” two rate it a “Moderate Buy,” and five recommend a “Hold.” Meanwhile, VTR’s average price target of $100.17 implies potential upside of 15.2% from the current share price.
On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
As the Order Book Swells, Akamai Stock Is Positioned for Growth Acceleration Buy, Sell, or Hold: How to Play Meta Platforms Stock After Its Q3 Earnings Beat SpaceX Turns Profitable. Investors Can Thank AI, Not Rockets or Starlink, for the SPCX Stock Win. 3 Defensive Stocks to Buy as the AI Selloff Rattles Wall Street